Latest Quarterly Results
Quarter Ended November 2, 2019
-3.5%
Comparable sales decline of 3.9% on an owned basis; comparable sales decline of 3.5% on an owned plus licensed basis.
$5.2B
Net Sales
$0.07
Diluted EPS of $0.01; $0.07 per share excluding restructuring and other costs.
Source:
For complete information regarding our financials, see our periodic filings.
Latest Financial Results
Q3 2019
Quarter Ended Nov 2, 2019